Unique Ingredient Identifier R8WTH25YS2 is listed as a ingredient substance
| RN | 99880-64-5 |
| EC | 278-717-5 |
| NCIT | C100065 |
| RXCUI | 1305749 |
UNII R8WTH25YS2 GLYCERYL DIBEHENATE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| ORAL | CAPSULE | 5.7 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 3.5 MG |
| ORAL | CAPSULE, HARD GELATIN | 2.7 MG |
| ORAL | POWDER, FOR ORAL SOLUTION | 2 MG |
| ORAL | POWDER, FOR ORAL SUSPENSION | 1971 MG/25.169GM |
| ORAL | SOLUTION | 3 MG |
| ORAL | TABLET | 14 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), COATED | 1.6 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 15.04 MG |
| ORAL | TABLET, DELAYED RELEASE | 12.5 MG |
| ORAL | TABLET, EXTENDED RELEASE | 142.5 MG |
| ORAL | TABLET, FILM COATED | 4 mg |
| ORAL | TABLET, ORALLY DISINTEGRATING | 5.6 MG |
| ORAL | TABLET, SUSTAINED ACTION | 50.6 MG |